HORN, J., Vojtěch THON, D. BARTONKOVA, U. SALZER, K. WARNATZ, M. SCHLESIER, HH. PETER and B. GRIMBACHER. Anti-IgA antibodies in Common Variable Immunodeficiency (CVID): Diagnostic workup and therapeutic strategy. CLINICAL IMMUNOLOGY. 2007, vol. 122, No 2, p. 156-162. ISSN 1521-6616.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Anti-IgA antibodies in Common Variable Immunodeficiency (CVID): Diagnostic workup and therapeutic strategy
Name in Czech Anti-IgA protilátky u běžné variabilní imunodeficience (CVID): vypracování diagnostické a terapeutické strategie
Authors HORN, J., Vojtěch THON, D. BARTONKOVA, U. SALZER, K. WARNATZ, M. SCHLESIER, HH. PETER and B. GRIMBACHER.
Edition CLINICAL IMMUNOLOGY, 2007, 1521-6616.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.551
Organization unit Faculty of Medicine
UT WoS 000243779300006
Keywords (in Czech) IgG anti IgA protilátky; běžná variabilní imunodeficience (CVID); IgA deficit
Keywords in English IgG anti IgA antibodies; Common Variable Immunodeficiency (CVID); IgA deficiency
Tags Common Variable Immunodeficiency (CVID), IgA deficiency, IgG anti IgA antibodies
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Vojtěch Thon, Ph.D., učo 2483. Changed: 18/6/2009 12:10.
Abstract
Common Variable Immunodeficiency (CVID) patients who are seropositive for anti-IgA antibodies have a predisposition for anaphylactoid reactions to intravenous immunoglobulin replacement therapy (IVIG). Among 88 CVID patients, we identified eight with IgG anti-IgA antibodies (9%). All eight completely tacked IgA (< 0.0009 g/l). Five of them had a history of anaphylactoid reactions to IVIG. However, four of these five patients tolerated subcutaneous immunoglobulin replacement therapy (SCIG). To identify predisposing factors for anti-IgA antibodies and related anaphytactoid reactions, we analyzed the clinical and immunological phenotype of affected patients. All eight IgG anti-IgA-positive patients tacked IgA(+) B cells in peripheral blood. Moreover, CVID patients with retained class-switched CD27(pos) IgM(neg) IgD(neg) memory B cells (Freiburg classification group II) and total IgA deficiency seem to have an increased risk for developing anti-IgA antibodies. In seven of the eight patients, lymphoproliferation was observed (most prominently nodular lymphatic hyperplasia), two had granulomatous disease, and two showed autoimmune phenomena.
Abstract (in Czech)
Anti-IgA protilátky u běžné variabilní imunodeficience (CVID): vypracování diagnostické a terapeutické strategie.
Links
NR9035, research and development projectName: Specifická protilátková odpověď u pacientů s poruchami imunity
PrintDisplayed: 13/7/2024 13:28